ASX - By Stock
|
ACW |
Re:
Ann: ACW March 2024 quarterly activity report & Appendix 4C
|
|
dunover
|
16 |
3.3K |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
16
|
3.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding - HNG
|
|
dunover
|
11 |
2.3K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
11
|
2.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding - HNG
|
|
dunover
|
11 |
2.3K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
11
|
2.3K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Proposed issue of securities - ACW
|
|
dunover
|
22 |
4.9K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
22
|
4.9K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
dunover
|
28 |
6.9K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
28
|
6.9K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
dunover
|
28 |
6.9K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
28
|
6.9K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
dunover
|
28 |
6.9K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
28
|
6.9K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW March 2024 quarterly activity report & Appendix 4C
|
|
dunover
|
16 |
3.3K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
16
|
3.3K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: First patient treated in ACW XanaMIA ph 2b Alzheimers trial
|
|
dunover
|
26 |
8.4K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
26
|
8.4K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: First patient treated in ACW XanaMIA ph 2b Alzheimers trial
|
|
dunover
|
26 |
8.4K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
26
|
8.4K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding - HNG
|
|
dunover
|
11 |
2.3K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
11
|
2.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding - HNG
|
|
dunover
|
11 |
2.3K |
1 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
11
|
2.3K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: First patient treated in ACW XanaMIA ph 2b Alzheimers trial
|
|
dunover
|
26 |
8.4K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
26
|
8.4K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Results of Meeting
|
|
dunover
|
3 |
1.2K |
1 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
3
|
1.2K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Beard
|
|
dunover
|
31 |
8.9K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
31
|
8.9K
|
0
|
|
Charts
|
ACW |
Re:
ACW Chart Thread
|
|
dunover
|
24 |
8.7K |
7 |
24/03/24 |
24/03/24 |
Charts
|
24
|
8.7K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Beard
|
|
dunover
|
31 |
8.9K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
31
|
8.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Beard
|
|
dunover
|
31 |
8.9K |
0 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
31
|
8.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Beard
|
|
dunover
|
31 |
8.9K |
0 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
31
|
8.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Beard
|
|
dunover
|
31 |
8.9K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
31
|
8.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Beard
|
|
dunover
|
31 |
8.9K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
31
|
8.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Organisational Changes
|
|
dunover
|
5 |
1.5K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
5
|
1.5K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Organisational Changes
|
|
dunover
|
5 |
1.5K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
5
|
1.5K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Organisational Changes
|
|
dunover
|
5 |
1.5K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
5
|
1.5K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: H1 FY24 Results and Corporate Update
|
|
dunover
|
17 |
4.8K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
17
|
4.8K
|
0
|
|
ASX - By Stock
|
IPB |
Re:
IPB Chart thread
|
|
dunover
|
1.9K |
285K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
1.9K
|
285K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: H1 FY24 Results and Corporate Update
|
|
dunover
|
17 |
4.8K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
17
|
4.8K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: H1 FY24 Results and Corporate Update
|
|
dunover
|
17 |
4.8K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
17
|
4.8K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding - HNG
|
|
dunover
|
4 |
985 |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
985
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding - HNG
|
|
dunover
|
4 |
985 |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
985
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen awarded UK Innovation Passport for Xanamem
|
|
dunover
|
73 |
17K |
1 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
73
|
17K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Application for quotation of securities - ACW
|
|
dunover
|
25 |
6.6K |
0 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
25
|
6.6K
|
0
|
|
ASX - By Stock
|
IPB |
Re:
Ann: Cancellation of General Meeting
|
|
dunover
|
21 |
3.9K |
6 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
21
|
3.9K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen awarded UK Innovation Passport for Xanamem
|
|
dunover
|
73 |
17K |
4 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
73
|
17K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
acw
|
|
dunover
|
26 |
8.5K |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
26
|
8.5K
|
1
|
|
ASX - By Stock
|
IPB |
Re:
Ann: Director Appointment/Resignation
|
|
dunover
|
50 |
8.8K |
2 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
50
|
8.8K
|
2
|
|
ASX - By Stock
|
IPB |
Re:
Ann: Director Appointment/Resignation
|
|
dunover
|
50 |
8.8K |
1 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
50
|
8.8K
|
1
|
|
ASX - By Stock
|
IPB |
Re:
Ann: Director Appointment/Resignation
|
|
dunover
|
50 |
8.8K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
50
|
8.8K
|
0
|
|
ASX - By Stock
|
IPB |
Re:
Ann: Director Appointment/Resignation
|
|
dunover
|
50 |
8.8K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
50
|
8.8K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Completion of Placement
|
|
dunover
|
10 |
2.7K |
2 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
10
|
2.7K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Completion of Placement
|
|
dunover
|
10 |
2.7K |
2 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
10
|
2.7K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
dunover
|
4 |
1.0K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
4
|
1.0K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
dunover
|
4 |
1.0K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
4
|
1.0K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
ACW up +21% in last 6 months , up +54% YTD, good upside momentum into 2024 & 2025 results
|
|
dunover
|
8 |
3.3K |
11 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
8
|
3.3K
|
11
|
|
ASX - By Stock
|
ACW |
Re:
is this true? Could ACW reach these prices based on where they are at right now?
|
|
dunover
|
3 |
1.7K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
3
|
1.7K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dunover
|
5 |
1.2K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
5
|
1.2K
|
1
|
|
ASX - By Stock
|
IPB |
Re:
IPB Chart thread
|
|
dunover
|
1.9K |
285K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
1.9K
|
285K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dunover
|
5 |
1.2K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
5
|
1.2K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem brain PET study peer-reviewed publication
|
|
dunover
|
39 |
12K |
4 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
39
|
12K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem brain PET study peer-reviewed publication
|
|
dunover
|
39 |
12K |
6 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
39
|
12K
|
6
|
|